1. Home
  2. PRA vs VCEL Comparison

PRA vs VCEL Comparison

Compare PRA & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProAssurance Corporation

PRA

ProAssurance Corporation

HOLD

Current Price

$24.05

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$37.52

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRA
VCEL
Founded
1976
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
2.0B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
PRA
VCEL
Price
$24.05
$37.52
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$22.50
$57.50
AVG Volume (30 Days)
405.2K
599.1K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
236.54
EPS
0.66
0.25
Revenue
$1,120,385,000.00
$258,716,999.00
Revenue This Year
N/A
$17.86
Revenue Next Year
$1.24
$18.55
P/E Ratio
$36.59
$152.71
Revenue Growth
N/A
14.05
52 Week Low
$13.90
$29.24
52 Week High
$24.41
$63.00

Technical Indicators

Market Signals
Indicator
PRA
VCEL
Relative Strength Index (RSI) 50.19 50.86
Support Level $24.14 $35.53
Resistance Level $24.16 $38.15
Average True Range (ATR) 0.10 1.31
MACD -0.01 0.07
Stochastic Oscillator 31.31 69.31

Price Performance

Historical Comparison
PRA
VCEL

About PRA ProAssurance Corporation

ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: